In gastrointestinal malignancies, investigators demonstrate marked upregulation of CKS2 in hepatocellular carcinoma8, gastric adenocarcinoma9, 10, colorectal cancer11, and esophageal squamous cell carcinoma12 compared to adjacent non-tumor tissues. This evidence concerns the gene CKS2 and neoplasm.